They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights
NVIDIA & Eli Lilly launch $1 billion AI Lab to reinvent drug discovery
AbbVie strikes deal with Trump administration on drug prices, US investment
Teva and Royalty Pharma partner in $500 million deal to fast-track vitiligo treatment
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
